Gut microbial diversity and candidate keystone taxa in Indian tribes: Insights across lifestyle-ecological continuum and health associations.
Authors: Mollick SA, Khual GK, Ghosh A, Patel SK, Bhattacharyya S, Roy CS, Maile A, Nagarajaram HA, Longkumer M, Babu MN, Kundapur AR, Uniyal S, Chattterjee A, Mitra M, Sikdar M, Urade BP, Pulamaghatta VN
Journal: Current research in microbial sciences
schizophrenia
mental health
open access
Abstract
Primary biliary cholangitis (PBC), previously termed primary biliary cirrhosis, is a chronic autoimmune disease that predominantly affects middle-aged women []. It is characterized histologically by chronic nonsuppurative destruction of the intrahepatic small bile ducts and clinically by cholestasis, and progressive liver dysfunction. Serologically, PBC is associated with elevated alkaline phosphatase (ALP) levels, γ-glutamyl transpeptidase (GGT) levels, and the presence of antimitochondrial antibodies (AMA) []. Accumulating evidence supports a substantial genetic contribution to PBC susceptibility. Familial aggregation, increased risk among first-degree relatives, and high concordance rates in monozygotic twins indicate a heritable component underlying disease development [–]. Genome-wide association studies (GWAS) have identified multiple risk loci involved in PBC [–]; however, these variants generally confer modest effect sizes and do not fully explain disease heritability. In contrast, rare germline variants with larger functional effects may play a critical role in familial PBC, yet such variants remain poorly characterized. Whole-exome sequencing provides an effective approach for identifying rare, potentially pathogenic variants in multiplex families [], but its application in familial PBC has been limited, and functional validation of candidate variants in vivo is scarce.